Lloyd Brian G. 4

Accession 0001415889-25-006311

CIK 0000856982other

View on SEC.gov Company Profile

Filed

Mar 2, 7:00 PM ET

Accepted

Mar 3, 8:24 PM ET

Size

21.8 KB

Accession

0001415889-25-006311

Insider Transaction Report

Form 4

Period: 2025-02-27

MERIT MEDICAL SYSTEMS INCMMSI

Lloyd Brian G.

CHIEF LEGAL OFFICER, SECRETARY

Transactions

Exercise/Conversion
Common Stock, No Par Value
2025-02-28$44.80/sh+25,000$1,120,000→ 63,993 total
Award
Common Stock, No Par Value
2025-02-28+7,056→ 38,993 total
Sale
Common Stock, No Par Value
2025-02-28$99.50/sh−25,000$2,487,500→ 38,993 total
Exercise/Conversion
Non-qualified stock options (right to buy)
2025-02-28−25,000→ 0 total
Exercise: $44.80From: 2019-03-02Exp: 2025-03-02→ Common Stock (25,000 underlying)
Award
Common Stock, No Par Value
2025-02-27+11,533→ 36,135 total
Tax Payment
Common Stock, No Par Value
2025-02-27$98.50/sh−4,198$413,503→ 31,937 total

Holdings

Non-qualified stock options (right to buy)
Exercise: $70.58From: 2024-02-28Exp: 2030-02-28→ Common Stock (13,576 underlying)
13,576
Non-qualified stock options (right to buy)
Exercise: $55.73From: 2020-03-01Exp: 2026-03-01→ Common Stock (30,000 underlying)
30,000
Non-qualified stock options (right to buy)
Exercise: $56.25From: 2022-03-19Exp: 2028-03-19→ Common Stock (9,681 underlying)
9,681
Non-qualified stock options (right to buy)
Exercise: $65.03From: 2023-02-28Exp: 2029-02-28→ Common Stock (8,094 underlying)
8,094
Non-qualified stock options (right to buy)
Exercise: $37.71From: 2021-02-26Exp: 2027-02-26→ Common Stock (16,722 underlying)
16,722

Footnotes (10)

[F1]These shares were acquired upon a determination of the Company's Compensation and Talent Development Committee that certain conditions had been met for the issuance of such shares pursuant to performance stock units that were granted on 02.28.2022.
[F10]Become exercisable in equal annual installments of 25% commencing on 02/28/2024.
[F2]The Reporting Person surrendered 4,198 shares of common stock to the Issuer for payroll taxes. No shares were sold in the open market.
[F3]Represents a grant of restricted stock units ("RSUs"). The RSUs vest in three equal annual installments on each of the first three anniversaries of the grant date, subject to the Reporting Person's continued service through the applicable vesting date. Each RSU represents the contingent right to receive one share of Common Stock upon vesting.
[F4]The price reported in Column 4 of Table 1 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $98.56 to $100.0525, inclusive. The Reporting Person undertakes to provide to Merit Medical Systems, Inc., any security holder of Merit Medical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
[F5]Become exercisable in equal annual installments of 20% commencing on 03/02/2019.
[F6]Become exercisable in equal annual installments of 20% commencing on 03/01/2020.
[F7]Become exercisable in equal annual installments of 25% commencing on 02/26/2021.
[F8]Become exercisable in equal annual installments of 25% commencing on 03/19/2022.
[F9]Becomes exercisable in equal annual installments of 25% commencing 02/28/2023.

Documents

1 file

4
form4-03042025_010352.xmlPrimary

Issuer

MERIT MEDICAL SYSTEMS INC

CIK 0000856982

→

Entity typeother

Related Parties

filerCIK 0001671772

Filing Metadata

Form type: 4
Filed: Mar 2, 7:00 PM ET
Accepted: Mar 3, 8:24 PM ET
Size: 21.8 KB

View on SEC.gov